183 related articles for article (PubMed ID: 19533526)
1. Sustained antinociceptive effect of cannabinoid receptor agonist WIN 55,212-2 over time in rat model of neuropathic spinal cord injury pain.
Hama A; Sagen J
J Rehabil Res Dev; 2009; 46(1):135-43. PubMed ID: 19533526
[TBL] [Abstract][Full Text] [Related]
2. Activation of spinal and supraspinal cannabinoid-1 receptors leads to antinociception in a rat model of neuropathic spinal cord injury pain.
Hama A; Sagen J
Brain Res; 2011 Sep; 1412():44-54. PubMed ID: 21813113
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid subtype-2 receptors modulate the antihyperalgesic effect of WIN 55,212-2 in rats with neuropathic spinal cord injury pain.
Ahmed MM; Rajpal S; Sweeney C; Gerovac TA; Allcock B; McChesney S; Patel AU; Tilghman JI; Miranpuri GS; Resnick DK
Spine J; 2010 Dec; 10(12):1049-54. PubMed ID: 20920894
[TBL] [Abstract][Full Text] [Related]
4. Antinociceptive effect of cannabinoid agonist WIN 55,212-2 in rats with a spinal cord injury.
Hama A; Sagen J
Exp Neurol; 2007 Mar; 204(1):454-7. PubMed ID: 17045264
[TBL] [Abstract][Full Text] [Related]
5. Physiological evidence of a postsynaptic inhibition of the tail flick reflex by a cannabinoid receptor agonist.
Dableh LJ; Yashpal K; Henry JL
Eur J Pharmacol; 2009 Jan; 602(1):36-40. PubMed ID: 19027734
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid receptor-mediated antinociception with acetaminophen drug combinations in rats with neuropathic spinal cord injury pain.
Hama AT; Sagen J
Neuropharmacology; 2010; 58(4-5):758-66. PubMed ID: 20035773
[TBL] [Abstract][Full Text] [Related]
7. A cannabinoid agonist, WIN 55,212-2, reduces neuropathic nociception induced by paclitaxel in rats.
Pascual D; Goicoechea C; Suardíaz M; Martín MI
Pain; 2005 Nov; 118(1-2):23-34. PubMed ID: 16213089
[TBL] [Abstract][Full Text] [Related]
8. Pronociceptive effects of spinal dynorphin promote cannabinoid-induced pain and antinociceptive tolerance.
Gardell LR; Burgess SE; Dogrul A; Ossipov MH; Malan TP; Lai J; Porreca F
Pain; 2002 Jul; 98(1-2):79-88. PubMed ID: 12098619
[TBL] [Abstract][Full Text] [Related]
9. Fatty acid amide hydrolase (FAAH) inhibitors exert pharmacological effects, but lack antinociceptive efficacy in rats with neuropathic spinal cord injury pain.
Hama AT; Germano P; Varghese MS; Cravatt BF; Milne GT; Pearson JP; Sagen J
PLoS One; 2014; 9(5):e96396. PubMed ID: 24788435
[TBL] [Abstract][Full Text] [Related]
10. Antinociceptive effect of intrathecal cannabinoid receptor agonist WIN 55,212-2 in a rat bone tumor pain model.
Cui JH; Kim WM; Lee HG; Kim YO; Kim CM; Yoon MH
Neurosci Lett; 2011 Apr; 493(3):67-71. PubMed ID: 21195743
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of repeated low dose treatment with the cannabinoid agonist WIN 55,212-2 in experimental models of bone cancer pain and neuropathic pain.
Hald A; Ding M; Egerod K; Hansen RR; Konradsen D; Jørgensen SG; Atalay B; Nasser A; Bjerrum OJ; Heegaard AM
Pharmacol Biochem Behav; 2008 Nov; 91(1):38-46. PubMed ID: 18611408
[TBL] [Abstract][Full Text] [Related]
12. Effects of a cannabinoid agonist on spinal nociceptive neurons in a rodent model of neuropathic pain.
Liu C; Walker JM
J Neurophysiol; 2006 Dec; 96(6):2984-94. PubMed ID: 16943316
[TBL] [Abstract][Full Text] [Related]
13. Topical cannabinoid antinociception: synergy with spinal sites.
Dogrul A; Gul H; Akar A; Yildiz O; Bilgin F; Guzeldemir E
Pain; 2003 Sep; 105(1-2):11-6. PubMed ID: 14499415
[TBL] [Abstract][Full Text] [Related]
14. Analgesic and antiinflammatory effects of cannabinoid receptor agonists in a rat model of neuropathic pain.
Leichsenring A; Andriske M; Bäcker I; Stichel CC; Lübbert H
Naunyn Schmiedebergs Arch Pharmacol; 2009 Jun; 379(6):627-36. PubMed ID: 19152053
[TBL] [Abstract][Full Text] [Related]
15. Low dose combination of morphine and delta9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptors.
Smith PA; Selley DE; Sim-Selley LJ; Welch SP
Eur J Pharmacol; 2007 Oct; 571(2-3):129-37. PubMed ID: 17603035
[TBL] [Abstract][Full Text] [Related]
16. Topical cannabinoid enhances topical morphine antinociception.
Yesilyurt O; Dogrul A; Gul H; Seyrek M; Kusmez O; Ozkan Y; Yildiz O
Pain; 2003 Sep; 105(1-2):303-8. PubMed ID: 14499448
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoids blocks tactile allodynia in diabetic mice without attenuation of its antinociceptive effect.
Doğrul A; Gül H; Yildiz O; Bilgin F; Güzeldemir ME
Neurosci Lett; 2004 Sep; 368(1):82-6. PubMed ID: 15342139
[TBL] [Abstract][Full Text] [Related]
18. Repeated treatment with the synthetic cannabinoid WIN 55,212-2 reduces both hyperalgesia and production of pronociceptive mediators in a rat model of neuropathic pain.
Costa B; Colleoni M; Conti S; Trovato AE; Bianchi M; Sotgiu ML; Giagnoni G
Br J Pharmacol; 2004 Jan; 141(1):4-8. PubMed ID: 14662732
[TBL] [Abstract][Full Text] [Related]
19. Exploring acute-to-chronic neuropathic pain in rats after contusion spinal cord injury.
Gaudet AD; Ayala MT; Schleicher WE; Smith EJ; Bateman EM; Maier SF; Watkins LR
Exp Neurol; 2017 Sep; 295():46-54. PubMed ID: 28552717
[TBL] [Abstract][Full Text] [Related]
20. Activation of peripheral cannabinoid receptors attenuates cutaneous hyperalgesia produced by a heat injury.
Johanek LM; Simone DA
Pain; 2004 Jun; 109(3):432-442. PubMed ID: 15157704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
